ArticleInternational journal of general medicine2026
A Machine Learning Model for Predicting Recurrent Pregnancy Loss: Retrospective Integration of Routine Serum IL-33, C-Reactive Protein, and Lymphocyte Subset Counts.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence in Recurrent Pregnancy Loss: From Risk Prediction to ART Translation.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Recurrent pregnancy loss (RPL), defined as two or more consecutive spontaneous miscarriages before 20 weeks of gestation, affects 2-5% of reproductive-age women globally, and current clinical predictors for it lack sufficient accuracy. This study aimed to construct a machine learning (ML) model for RPL prediction by integrating serum IL-33, C-reactive protein (CRP), and lymphocyte subset counts, and validate its performance in a retrospective cohort. Methods: A total of 340 reproductive-age women from XiDian Group Hospital and Xi'an Traditional Chinese Medicine Hospital (January 2020-December 2024) were enrolled. Baseline clinical characteristics, IL-33, CRP levels, and lymphocyte subset counts were collected as predictors, with RPL as the primary outcome. The dataset was split into a training set (70%) and a validation set (30%). Logistic regression, random forest, and XGBoost were trained with hyperparameter optimization via grid search, and model performance was evaluated by AUC, accuracy, sensitivity, specificity, PPV, and NPV. Results: Of the 340 participants, 85 (25.0%) had RPL and 255 (75.0%) did not. The RPL group had significantly lower IL-33 and CD4+/CD8+ ratio, higher CRP and NK cell proportions (all p < 0.001). XGBoost outperformed the other two models, with an AUC of 0.89 (95% CI: 0.82-0.96) in the training set and 0.85 (95% CI: 0.76-0.94) in the validation set; its validation set accuracy, sensitivity, specificity, PPV and NPV were 88.1%, 82.4%, 88.7%, 28.6% and 98.7%, respectively. Conclusion: The ML model integrating IL-33, CRP, and lymphocyte subset counts shows good discriminatory ability for RPL, providing a preliminary reference for identifying high-risk women in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.